Please assess the completion status of the following clinical trial:

Trial Title: A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~All subjects must:~1. Be willing and able to provide written Informed Consent.~2. Be able and willing to follow instructions on the use of post- operative medication and likely to complete the entire course of the study.~3. Be male or female of any race at least 18 years of age.~4. Have medically uncontrolled glaucoma for which they have elected to undergo surgery.~5. Diagnosed with primary open angle glaucoma, pigmentary or pseudoexfoliation glaucoma.~Exclusion Criteria:~No subject may:~1. Have any contraindication to intraocular surgery.~2. Diagnosed with: primary angle closure glaucoma, normal tension glaucoma, secondary glaucoma, neovascular glaucoma.~3. Have any active ocular disease other than glaucoma that would interfere with study parameters (such as: uveitis, ocular infection, or severe dry eye). Subjects with mild chronic blepharitis, age-related macular degeneration and background diabetic retinopathy may be enrolled at the discretion of the investigator.~4. Have laser ALT or SLT within the past 3 months or cataract surgery within the last six months.~5. Require use of ocular NSAID or systemic steroids.~6. Have known allergy or sensitivity to mitomycin C~7. Have corneal abnormalities that would interfere with the ability to obtain an adequate laser flare measurement.~8. Be concurrently enrolled in an investigational drug or device study or participation within the last 30 days in any investigational drug or device study.~9. Be pregnant, nursing, planning a pregnancy, or be of childbearing potential and not using a reliable form of contraception (a woman is considered of childbearing potential unless she is postmenopausal, has had a uterus and/or both ovaries removed, or has had a bilateral tubal ligation).~10. Have a situation or condition that in the investigator's opinion may put the subject at significant risk, may confound the study results, or may interfere significantly with participation in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Trabeculectomy with Mitomycin C 0.2 mg/cc for 2 minutes
- 2 (Type: ACTIVE_COMPARATOR): Ex-Press mini shunt; Model R50 with mitomycin C 0.2 mg/cc for 2 minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).